Hypera Pharma | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

9,938 results for “Hypera Pharma”

Trials

View all 4364 →

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

First posted Jun 12, 2006

Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)

24 participants · First posted Jun 29, 2016

Exjade-Early-Trial

2 participants · First posted Jan 28, 2010

Drugs

View all 1141 →

Thalidomide inhalation (Vicore Pharma)

Ezetimibe/obicetrapib (NewAmsterdam Pharma)

DiPOA (Purdue Pharma)

Organizations

View all 1228 →

Bioprojet Pharma

Belgium

ACASTI PHARMA INC

United States

Innate Pharma, Inc.

United States

News

View all 3205 →

EMS Acquires Sanofi's Medley for $500M, Plans Semaglutide Generic Launch in Brazil

Hypera to Launch Generic Semaglutide in Brazil Ahead of 2026 Patent Expiration

Novo Nordisk Invests $1.09 Billion to Expand GLP-1 Production Capacity in Brazil

Page 1 of 994